Ischemic Stroke Clinical Trial
Official title:
Adapting Tools to Implement Stroke Risk Management to Veterans
The purpose of this study is to develop and evaluate the local adaptation of existing stroke
prevention tools into practice. A stroke prevention program is a collection of materials
including written materials like pamphlets and brochures, videotapes and training guides for
stroke survivors and evidence based guidelines for the doctors that provide care for them.
Other tools that may be used in a stroke prevention program include devices that help
patients monitor medical symptoms at home like home blood pressure machines or blood sugar
monitors and messaging devices that allow reporting symptoms from home to a health care
provider.
We hypothesized Veterans with stroke who receive the Veteran Stroke Prevention Program would
engage in better medication compliance and stroke specific quality of life compared to those
who did not receive the program.
Stroke affects at least 15,000 veterans each year, and this number will likely increase as
the veteran population ages. According to the American Heart Association, the prevalence of
stroke is expected to double by 2020 with the increased proportion of older adults
nationwide. Our preliminary Quality Enhancement Research Initiative work indicates that
stroke risk factors are often undermanaged in the Veterans Health Administration.
This proposed study of a stroke risk factor management program may benefit the Veteran Health
System in several ways. First, it offers a systematic program for reduction in stroke risk
factors leading to better health for our veterans and a reduction in inpatient and outpatient
rehabilitation and home health services for these events. Second, the Veteran Stroke
Prevention Program takes into account the varied resources and services offered in VAMCs
across the nation, allowing the program to be tailored both to a given facility and to the
individual veteran's needs and readiness to change. Importantly, the program could allow all
VA facilities to offer guideline-concurrent stroke risk reduction programs and therefore
increase compliance with VA/Department of Defense, American Heart Association, and the Joint
Commission stroke care guidelines and improve their quality of stroke care.
Comparison(s): We will compare two regionally matched facilities on rates of secondary stroke
prevention guideline care during the course of the study at the intervention sites.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 |